Literature DB >> 31236261

Epidemiology of Alcohol Use and Alcoholic Liver Disease.

Jessica L Mellinger1.   

Abstract

Entities:  

Year:  2019        PMID： 31236261      PMCID： PMC6544412          DOI： 10.1002/cld.806

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  10 in total

1.  Health-related quality of life is dynamic in alcoholic hepatitis and responds to improvement in liver disease and reduced alcohol consumption.

Authors:  Abhishek Madathanapalli; Qing Tang; Craig Lammert; Niharika Samala; Vijay H Shah; Arun Sanyal; Naga Chalasani; Archita P Desai
Journal:  Alcohol Clin Exp Res       Date:  2021-12-16       Impact factor: 3.455

2.  Change in Alcohol Use and Association with Positive and Negative Emotions: Results from an Alcohol Treatment Study with Hepatitis C Patients.

Authors:  Malik Muhammad Sohail; Jia Yao; Donna M Evon; Andrew J Muir; Rae Jean Proeschold-Bell
Journal:  Alcohol Treat Q       Date:  2021-01-03

Review 3.  Natural Recovery by the Liver and Other Organs after Chronic Alcohol Use.

Authors:  Paul G Thomes; Karuna Rasineni; Viswanathan Saraswathi; Kusum K Kharbanda; Dahn L Clemens; Sarah A Sweeney; Jacy L Kubik; Terrence M Donohue; Carol A Casey
Journal:  Alcohol Res       Date:  2021-04-08

4.  Trends in US Alcohol Consumption Frequency During the First Wave of the SARS-CoV-2 Pandemic.

Authors:  Sarah McKetta; Christopher N Morrison; Katherine M Keyes
Journal:  Alcohol Clin Exp Res       Date:  2021-03-03       Impact factor: 3.928

5.  Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice.

Authors:  Kayla Frank; Shawn Abeynaike; Rana Nikzad; Reesha R Patel; Amanda J Roberts; Marisa Roberto; Silke Paust
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

6.  The symptom discounting effect: what to do when negative genetic test results become risk factors for alcohol use disorder.

Authors:  Woo-Kyoung Ahn; Annalise M Perricone
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

7.  Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against alcoholic liver disease.

Authors:  Shi Qiu; Ai-Hua Zhang; Yu Guan; Hui Sun; Tian-Lei Zhang; Ying Han; Guang-Li Yan; Xi-Jun Wang
Journal:  RSC Adv       Date:  2020-01-15       Impact factor: 4.036

8.  Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic.

Authors:  Jessica L Mellinger; Gerald Scott Winder; Anne C Fernandez; Kristin Klevering; Amanda Johnson; Haila Asefah; Mary Figueroa; Jack Buchanan; Fred Blow; Anna S F Lok
Journal:  J Subst Abuse Treat       Date:  2021-04-09

9.  Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD.

Authors:  Hani Shamseddeen; Abhishek Madathanapalli; Vijay S Are; Vijay H Shah; Arun J Sanyal; Qing Tang; Tiebing Liang; Kayla Gelow; Teresa A Zimmers; Naga Chalasani; Archita P Desai
Journal:  Dig Dis Sci       Date:  2020-10-19       Impact factor: 3.487

10.  Alox12/15 Deficiency Exacerbates, While Lipoxin A4 Ameliorates Hepatic Inflammation in Murine Alcoholic Hepatitis.

Authors:  Alexander Queck; Annika F Fink; Evelyn Sirait-Fischer; Sabrina Rüschenbaum; Dominique Thomas; Ryan G Snodgrass; Gerd Geisslinger; Hideo A Baba; Jonel Trebicka; Stefan Zeuzem; Andreas Weigert; Christian M Lange; Bernhard Brüne
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.